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Highlights: 
- Sartans containing an imidazolic-like ring are degraded by free chlorine.   
- Removal of reactive sartans fits a pseudo-first order kinetics model. 
- Maximum degradation rates are observed at neutral, or slightly acidic, pHs. 
- Imidazole halogenation represents the main reaction route of Losartan. 
- Hydrolysis of the imidazolone ring explains most of the Irbesartan derivatives. 
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Abstract 
Angiotensin II receptor antagonists (ARA II) are widely employed in the treatment of 
hypertension-related diseases. Because of their partial metabolization and limited 
biodegradability, these drugs have become ubiquitous pollutants in the aquatic environment, 
including surface water. This research evaluated the reactivity of the ARA II drugs: irbesartan 
(IRB), losartan (LOS) telmisartan (TEL) and valsartan (VAL) with free chlorine. Responses of 
parent compounds and their transformation products (TPs) were followed by liquid 
chromatography (LC) with quadrupole (Q) time-of-flight (TOF) mass spectrometry. 
Degradation experiments were carried out using ultrapure and river water samples, adjusted 
at different pHs and, in some cases, adding a small amount (ng mL-1 level) of bromide salts. 
Whilst TEL and VAL remained stable in presence of relatively high concentrations of free 
chlorine (10 mg L-1), IRB and LOS were removed according to a pseudo-first order kinetics 
model. Considering an initial chlorine concentration of 10 mg L-1, their half-lives varied between 
6 and 734 min, depending mostly on the water pH. IRB reacted with free chlorine through 
hydroxylation processes, with and without molecular cleavage and re-arrangements in the 
imidazolone ring. Its TPs showed a lower in-silico predicted toxicity than the parent drug. In 
case of LOS, two major competitive degradation routes were identified. They involved 
replacement of the methanol group attached to the imidazole cycle by chlorine or bromine, and 
the cleavage of this cycle with removal of the chlorinated carbon and the nitrogen in alpha 
position. The TPs generated following the first route are predicted to be more toxic than LOS. 
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Angiotensin II receptor antagonists (ARA II) are a group of pharmaceuticals employed in the 
treatment of hypertension-related diseases. They are also termed under the generic name of 
sartans. The ageing and the lifestyle of occidental societies have led to a steady increase in 
the prescription of these drugs (Kasprzyk-Horden et al., 2009; Ortiz de García et al., 2013). 
Sartans are mostly excreted as parent compounds, with percentages of metabolization below 
25% (Bayer et al., 2014). Consequently, they are present in urban sewage water at 
concentrations in the ng per mL-1 range (Bodík et al., 2016; Oosterhuis et al., 2013; Stankiewicz 
et al., 2015). Their mass balances in conventional sewage treatment plants (STPs), equipped 
with primary and activated sludge units, showed variable, yet incomplete removal efficiencies. 
The levels of sartan drugs in the outlet streams of conventional STPs (equipped with primary 
and biological treatment units) represent between 20% and 80% of those found in influents 
(Gurke et al., 2015; Hermes et al., 2018; Kostich et al., 2014). Thus, sartans have also polluted 
the surface water compartment. In rivers impacted by the discharges of STPs, their 
concentrations stay in the range from 10 to 500 ng L-1 (Giebułtowicz and Nałecz-Jawecki, 2016; 
Huerta-Fontela et al., 2011; Kasprzyk-Horden et al., 2008). 
The stability of several ARA-II drugs, detected in polluted water resources, through the different 
stages involved in the production of drinking water has been previously reported (Giebułtowicz 
and Nałecz-Jawecki, 2016; Huerta-Fontela et al., 2011). Some data on the occurrence of 
sartans, and their primary biodegradation products at STPs (such as valsartan acid), in finished 
tap water have been also published (Giebułtowicz and Nałecz-Jawecki, 2016). However, no 
information is available neither regarding the variables affecting their half-lives (t1/2) during 
chemical treatments of polluted waters (as those employed in the production of tap water), nor 
above the possible formation of transformation products (TPs) during these processes. To the 
best of our knowledge, the only TPs reported for sartan drugs correspond to those formed 
during biological treatment of urban wastewater (Letzel et al., 2015).  
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Free chlorine is one of the most popular oxidants during production of drinking water. Usually, 
pre-chlorination is the first step in the treatment of surface and/or groundwater resources. Free 
chlorine is also added to finished tap water in order to maintain its microbiological quality 
through the net of distribution pipes (Gibs et al., 2007; Postigo and Richardson 2014). Thus, 
residues of sartans existing in water catchments, and/or resisting to previous treatments (i.e. 
ozonisation, carbon filtration) applied during tap water production, might react with free chlorine 
leading to TPs with different chemical structures, and thus presenting different risks, than the 
parent pharmaceuticals, as it has been demonstrated for other emerging pollutants (Gibs et 
al., 2007; Temussi et al., 2013). 
The aim of this research is to assess, for the first time, the behaviour of four sartans (irbesartan, 
IRB; losartan, LOS; telmisartan, TEL; and valsartan, VAL) during the treatment of surface 
water with free chlorine, at a laboratory scale. Except TEL, selected compounds present a 
biphenyl structure connected to a tetraazolic ring, which is considered as recalcitrant to 
biodegradation processes at STPs (Nödler et al., 2013). In Europe, VAL and IRB are the ARA 
II drugs with the highest consumption rates (Letzel et al., 2015); thus, they are susceptible to 
contaminate tap water sources. LOS was the first of the sartan drugs approved for the 
treatment of hypertension; nowadays, it is still prescribed for this purpose. Herein, the 
degradation rates of parent compounds, the identification and structural characterization of 
their TPs, and the in-silico estimation of their relative toxicities (versus those assigned to 
precursor molecules) are discussed. LC-QTOF MS is employed as analytical technique in the 
kinetics study and during elucidation of the structures of TPs. A preliminary evaluation of the 
TPs toxicities was obtained from quantitative structure-activity relationship (QSAR) data, using 
the ECOSAR, version 2.0, software package (https://www.epa.gov/tsca-screening-
tools/ecological-structure-activity-relationships-ecosar-predictive-model). 
2. Material and methods 
2.1. Chemicals and samples 
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Standards of IRB, LOS (as potassium salt), TEL and VAL were obtained from Sigma-Aldrich 
(Milwakee, WI, USA). Their chemical structures and some relevant physico-chemical 
properties are shown in Table 1. Positions in imidazolic cycles of IRB (imidazolone) and LOS 
(imidazole) are numbered, from 1 to 5 (see Table 1), to facilitate the discussion of their 
reactions with free chlorine. A standard of compound CAS number 748812-53-5, acquired from 
Sigma-Aldrich, was employed to discriminate between two possible structures compatible with 
the spectral data obtained for one of the TPs of IRB. Standards of each compound (600-1000 
mg L−1) were prepared in methanol, further dilutions and mixtures were made in the same 
solvent. The linear response range of the LC-QTOF MS system was evaluated with a second 
set of standards in ultrapure water.  
Methanol (MeOH), HPLC-grade purity, sodium hydroxide and hydrochloric acid (37%) were 
purchased from Merck (Darmstadt, Germany). Ultrapure water (18.2 MΩ cm-1) was obtained 
from a Milli-Q Gradient A-10 system (Millipore, Bedford, MA, USA). Potassium bromide, 
dipotassium hydrogen phosphate, potassium dihydrogen phosphate and ascorbic acid were 
supplied by Sigma- Aldrich (Steinheim, Germany). Solutions of the above salts were prepared 
in ultrapure water. Sodium hypochlorite (6-14% w/v) was acquired from Sigma-Aldrich. The 
exact concentration of this solution was determined by reaction with N,N-diethyl-p-
phenylenediamine, with photometric detection (Clesceri et al., 1998), before being used in 
chlorination experiments.  
River water, not affected by discharges from STPs, was obtained from a local stream. The 
sample was first filtered (using 0.45 µm filters) and then characterized in terms of carbon and 
inorganic species contents. The obtained values were: 1.4, 8.4, 8.4, 7.0 and 0.007 mg L-1 of 
dissolved organic carbon, chloride, nitrate, sulfate and bromide ions, respectively. This matrix 
was used as representative of a catchment for drinking water production. 
 
2.2. Chlorination experiments 
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The reactions between sartans and free chlorine were investigated in closed amber vials. A 
small volume (50-200 µL) of a methanolic standard of the considered compound was poured 
into the reaction vessel; then, 10 mL of water (ultrapure or the above described filtered river 
water) were added and the solution was homogenized in a vortex stirrer. Solutions were 
buffered at different pHs, in the range from pH 5 to 9 units, adding 1 mL of a 0.03 M solution 
of KH2PO4/K2HPO4. In some assays, potassium bromide was also introduced in the reaction 
vessel at levels from 0.067 to 0.30 mg L-1 (as bromide). Unless otherwise stated, the initial 
concentration of parent drugs was 0.250 mg L-1 (from 4.9 to 5.9 x 10-7 M, depending on their 
molecular weights). Free chlorine was added at concentrations of 2 or 10 mg L-1 (equivalent to 
2.82 x 10-5 and 1.41 x 10-4 M, respectively), depending on the experiment. In both cases, a 
large molar excess of oxidant was employed. Thereafter, reaction vessels were capped, 
shaken for 2-3 s and left at room temperature (20 ± 2 ºC). Aliquots of 1 mL were collected at 
increasing times, from zero (before chlorine addition) to 1-48 h (depending on the rate of 
compounds degradation). Each reaction time aliquot was introduced in a 2 mL autosampler 
vial containing 0.01 mL of ascorbic acid (60 mg mL-1 solution in ultrapure water) to remove free 
chlorine and, thus, to stop any further oxidation reaction (Negreira et al., 2012). Vials were 
stored at 4 ºC and injected in the LC-QTOF MS instrument, within the next 24 h.  
A set of control experiments was performed with spiked water samples, buffered at different 
pHs (from 5 to 9 units), without chlorine addition. In this way, it was verified that sartans do not 
undergo other transformation reactions (e.g. hydrolysis), apart from those promoted by free 
chlorine. A second set of control assays was prepared in presence of chlorine, but without 
addition of sartans. Thus, false TPs, not correlated to parent compounds but arising from 
chlorine reaction with other organic species existing in river water, could be noticed.  
2.3. Instrumentation 
Parent compounds and their TPs were determined using a LC-QTOF MS instrument supplied 
by Agilent (Wilmington, DE, USA). The LC was an Agilent 1200 series consisting of a 
membrane degasser, two isocratic pumps, a chromatographic oven and an autosampler. The 
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QTOF mass spectrometer was an Agilent 6520 model, equipped with a dual electrospray ion 
source. Chromatographic separations were carried out in a UltisilTM C18 column (2.1 mm × 100 
mm, 3 µm) provided by Welch Materials (Zhejiang, China). The analytical LC column was 
connected to C18 guard cartridge (4 mm × 2 mm) supplied by Phenomenex (Torrance, CA, 
USA). Ultrapure water (A) and MeOH (B), both 0.1% in formic acid, were used as mobile 
phases. The LC gradient was programmed as follows: 0-0.5 min, 20% B; 15-17 min, 100% B; 
18-29 min, 20% B. Column flow and temperature were set at 0.2 mL min-1 and 30 ºC, 
respectively. The injection volume of the different reaction time water aliquots was 30 µL. 
Nitrogen (99.999%), used as nebulizing and drying gas in the electrospray ionisation source 
(ESI), was provided by a nitrogen generator (Erre Due srl, Livorno, Italy). Nitrogen (99.9995%) 
for collision-induced dissociation (MS/ MS measurements) was purchased from Praxair (A 
Coruña, Spain). The ESI source was either operated in the (+) or (-) ionization modes, 
depending on the LC-QTOF MS experiment. The rest of ESI parameters were: drying gas 
temperature and flow-rate, 350 ºC and 7 L min-1, respectively; nebulizer gas pressure, 30 psi; 
capillary voltage, 4500 V; and fragmentor voltage, 150 V. The TOF instrument was operated 
at 2 GHz (extended-dynamic range mode) providing FWHM resolutions from 5000 (at m/z 121) 
to 10000 (at m/z 922 Da).  
LC-QTOF MS control, data acquisition and processing were performed with the MassHunter 
Workstation B.08.00 software (Agilent Technologies). The kinetics of chlorination reactions 
were followed in the ESI(+) mode, from responses obtained for the [M+H]+ ions of each parent 
drug (mass extraction window 10 ppm). The search of TPs was carried out in the LC-MS 
chromatograms acquired in both ionization modes (ESI+/-). MS spectra were recorded (at 2 
spectra s-1) in the range from 100 to 950 m/z units. LC-ESI MS records for control and different 
reaction time aliquots (n=3 replicates) were processed with the MassHunter Profinder 
software. This algorithm provides a list of molecular features with different intensities (potential 
TPs) in the above chromatograms. The empirical formula for each TPs was generated 
considering the accurate masses and the isotopic profiles for the clusters of ions in their ESI 
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(+)-MS and ESI (-) MS spectra. Normalized scores (1-100), accounting for mass accuracy and 
isotopic profile, are calculated from the fitting between the experimental spectra (in both 
ionization modes) and the expected (theoretical) ones for the empirical formula proposed for 
each TP. The ESI (+/-) MS/MS (product ion scan) spectra of each TP were acquired (4 spectra 
s-1), in further LC runs, using different collision energies (5-40 eV). These spectra were 
interpreted for structural elucidation of the previously detected TPs. 
2.4. In-silico ecotoxicity assessment 
The ecotoxicity of parent sartans and their TPs to aquatic organisms were predicted using the 
ECOSAR software, freely available from the US Environmental Protection Agency (EPA). 
Predictions are based on the similarity of the investigated compound (parent drug or TP) to a 
set of chemicals, used to construct the QSAR model, whose environmental toxicities towards 
different organisms has been experimentally determined (Melnikow et al., 2016; Nika et al., 
2017). In this work, 48-h Daphnia magna LC50 (50% lethal concentration), 96-h fish LC50 and 
96-h green algae half-maximum effective concentration (EC50) were estimated. In addition, 
the chronic exposure toxicity values were obtained from the mean of non-observed effect 
concentration (NOEC) and the lowest observed effect concentration (LOEC), both predicted 
by ECOSAR software. 
3. Results and discussion 
3.1. Degradation kinetics 
The linearity in the response of the LC-ESI(+) TOF MS system for parent drugs was 
investigated in the range of concentrations between 1 and 1000 µg L-1. Within this interval, the 
plots of peak area versus concentration fitted a linear trend with determination coefficients (R2) 
above 0.996. All compounds showed signal to noise ratios (S/N) above 10 for the lowest level 
standard solution. Thus, using 0.250 mg L-1 as their initial concentration in chlorination 
experiments, the potential degradation of sartans could be followed in an extent above 99%. 
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Preliminary degradation experiments were carried out with ultrapure water aliquots (pH 6.0), 
individually spiked with the investigated compounds, in presence of 10 mg L-1 of free chlorine. 
Chlorine concentration and water pH can be considered as representative of those existing 
during pre-chlorination of raw water at drinking water production plants (Huerta-Fontela et al., 
2011; Quintana et al., 2014). Solutions were allowed to react overnight (16 h), at room 
temperature. Thereafter, chlorine was removed and the response measured for each drug was 
compared with that obtained for the zero time aliquots. Chlorination assays and control 
experiments (without chlorine) were performed in triplicate. All compounds were stable in 
control samples. The concentrations of TEL and VAL remained also constant in the chlorinated 
water samples (non-significant variations after 16 h, n=3 replicates), whereas the levels of IRB 
and LOS were reduced around 90 and 95%, respectively. Fig. S1 shows the stability in the 
responses of TEL and VAL for reaction times between 2 and 16 h, in presence of 10 mg L-1 of 
free chlorine. Thus, taking into account the relatively high concentration of chlorine, and the 
long reaction time employed in these previous experiments, only IRB and LOS are expected 
to undergo significant transformation reactions during free chlorine-based water disinfection 
treatments. 
The effect of pH in the degradation rates of IRB and LOS was evaluated in the interval between 
5 and 9 units. Assays were carried out in ultrapure water, using 10 mg L-1 as the initial 
concentration of free chlorine. Reaction times aliquots were withdrawn at different times and 
the measured responses normalized to those observed at zero time. Then, the natural 
logarithmic of normalized values were plotted versus time. As compiled in the supplementary 
information (Table S1), the determination coefficients (R2) of these graphs stayed above 0.990. 
Thus, within the investigated range of pH, the reactions of IRB and LOS with free chlorine 
followed pseudo-first order kinetics model. The values for their reaction rate constants (k, M-1 
min-1), and the t1/2 data are also included in Table S1.  
Fig. 1 illustrates the dependence between the obtained t1/2 data and the water pH. The t1/2 
values of LOS increased slightly from pH 5 to 7. Above pH 7, the stability of this drug increased 
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dramatically. In case of IRB, the measured t1/2 increased smoothly when the pH of the water 
sample differed from 7. At basic pHs, the acid-base equilibrium of HOCl (pKa 7.58) is shifted 
towards the hypochlorite anion, which is less reactive than the acid form. At pH 5 the 
imidazolic-like sub-structure existing in the molecules of IRB and LOS is partially protonated, 
Table 1. In case of IRB the protonated imidazolone ring is believed to be less reactive than the 
neutral form. This hypothesis will explain the decrease of the t1/2 of this sartan between pH 5 
and 7. For LOS, the equilibrium between protonated and neutral forms of the imidazole ring 
did not affect its reactivity with free chlorine. Thus, the lower the sample pH the higher the 
concentration of HOCl, consequently the degradation of LOS was faster.  
 
In addition to pH, the kinetics of reactions with free chlorine may be affected by organic and 
inorganic species existing in surface water. To investigate these effects, t1/2 values were also 
calculated adding a small concentration of bromide (0.067 mg L-1 and 0.1 mg L-1 for ultrapure 
and river water, respectively) to samples. Experiments were performed at pH 7, using chlorine 
concentrations of 2 and 10 mg L-1 for IRB and LOS, respectively.Table 2 shows the obtained 
data. The degradation rate of IRB remained unaffected by the addition of bromide traces to 
both water matrices; however, the t1/2 values in river water were twice longer than in ultrapure 
water. Regarding LOS, without bromide addition, similar t1/2 were observed for ultrapure and 
river water. Addition of potassium bromide speed up the removal of LOS in both matrices, 
Table 2. Usually, bromide traces increase the rate of the reactions with free chlorine when 
parent compounds undergo halogenation processes (Quintana et al., 2014). In summary, the 
effects of pH, bromide and water matrix in the half-lives of IRB and LOS (Fig. 1 and Table 2, 
respectively) indicate that, although both drugs contain similar functionalities in their chemical 
structures (Table 1), they probably react with free chlorine following different routes. 
 
3.2. Identification and characterization of TPs. 
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Table 3 summarizes the TPs detected in chlorination experiments. The list of compounds is 
limited to those displaying responses above 0.5% of that measured for the precursor drug 
(initial concentration 1 mg L-1) at zero time. TPs are labelled according to the discussion of 
their chemical structures in further paragraphs. In addition to retention times and empirical 
formulae, the number of double bond equivalents (DBEs) and the normalized scores (values 
from 0-100, calculated as described in section 2.3), corresponding to the cluster of ions in their 
ESI (+) and ESI (-) MS spectra, are included in Table 3. Same data are also provided for the 
precursor drugs. 
TPs arising from IRB incorporated extra atoms of oxygen, maintaining the same number of 
carbons. LOS led to halogenated (LOS-TPs 1 and 2), molecular cleavage (LOS-TPs 3 and 4) 
and a hydroxylated derivative (LOS-TP5). Compounds compiled in Table 3 were noticed in 
chlorination experiments with ultrapure and river water. The exception was IRB-TP4, which 
was found only in the ultrapure water chlorination assays. It is worth noting that, the brominated 
derivative of LOS (LOS-TP2) was formed even without increasing the level of bromide (0.007 
mg L-1) existing in the employed river water matrix. The structures of TPs compiled in Table 3 
are discussed on the basis of fragment ions, observed in their ESI(+) and ESI(-) MS/MS 
spectra, recorded at different collision energies in the range from 5 to 40 eV. The most probable 
formula of each fragment was proposed with the aid of the MassHunter software, considering 
the elemental composition of the precursor  ([M+H]+ or [M-H]-) ion. 
  
Irbesartan 
IRB-TP1 is a hydroxylated compound with the same DBE number as IRB, Table 3. Their ESI(+) 
product ion spectra contain a common fragment at m/z 207 Da (nominal value), which was 
assigned to the tetraazolic biphenyl moiety (C14H11N4+) after losing two atoms of nitrogen 
(C14H11N2+), Fig. 2A and 2B. The product ion at m/z 195.1489 u in the spectrum of IRB, which 
has been assigned to the imidazolone ring, appears at 211.1430 u in case of IRB-TP1.Thus, 
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hydroxylation necessarily occurred in any of the butyl chains (the linear or the cyclic one) 
connected to the imidazolone sub-structure. This assumption is confirmed with fragments in 
their ESI(-) MS/MS spectra provided as supplementary material (Fig. S2). Unfortunately, the 
ESI(+/-) MS/MS spectra of this TP did not contain enough information to established which of 
the alkyl carbons was hydroxylated. IRB-TP1 was tentatively assigned to IRB hydroxylated in 
the terminal carbon of the linear butyl chain. This compound has been previously proposed as 
one of the TPs formed during the biodegradation of IRB in laboratory scale STPs (Letzel et al., 
2015). 
The spectra of IRB-TP2 are shown in Fig. 3. Fragments at m/z 252, 235 and 207 Da (nominal 
values) in the ESI(+) product ion spectrum (Fig. 3A) suggest hydroxylation of IRB followed by 
cleavage of one of the bonds with nitrogen 1 in the imidazolone cycle, Table 1. The two 
possible products of this reaction are a carboxylic acid or an amide, depending on whether 
hydroxylation takes place in carbon 5, or in carbon 2, of IRB, respectively. The carboxylic acid 
has been reported as a biodegradation product of IRB at STPs (Letzel et al., 2015), whilst the 
amide is known to be an impurity formed during the synthesis of IRB (Chando et al., 1997). 
Structures assigned to the rest of product ions in the ESI(+) spectrum of IRB-TP2 are 
compatible with both species. When examining the ESI(-) spectrum of the same TP (Fig. 3B), 
the product ion at 305.1650 u (assigned to fragment ion C20H21N2O), and other fragment ions 
at lower m/z values (i.e. those at 211.1445 and 100.0768 u) point out to the amide structure. 
Final confirmation of the identity of IRB-TP2 was obtained by injection of a commercial 
standard of the amide derivative (CAS number 748812-53-5). Thus, IRB-TP2 is the result of 
hydroxylation of the imine carbon (carbon 2 in the imidazolone cycle of IRB, Tabe 1), followed 
by cleavage of the single bond between carbon 2 and nitrogen number 1 in the same cycle.  
IRB-TPs 3 and 4 present the same empirical formula and DBE number as IRB-TP1; however, 
their spectra contain different fragments. The ESI (+) MS/MS spectrum of IRB-TP3 (Fig. 4A) 
shares some common ions with that of IRB-TP2 (Fig. 3A), such as those at 252 and 235 Da. 
Other ions differ in 2 Da (fragments at 194 and 166 Da for IRB-TP3, versus 196 and 168 for 
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IRB-TP2). A structure compatible with the spectrum in Fig. 4A corresponds to intramolecular 
cyclization between the hydroxylated terminal carbon of IRB-TP1 and carbon number 2 in the 
imidazolone cycle (Table 1), with further opening of this ring.  
The ESI(+) MS/MS spectrum of IRB-TP4 (Fig.4B) contains fragments at higher m/z ratios than 
those observed for above described TPs. The product ion at m/z 250.1084 u (experimental 
value) suggest a similar structure to that of IRB-TP2 (Fig. 3A), but with an additional double 
bond. Likely, this unsaturation is located between the carbon in alpha to the biphenyl ring and 
the atom of nitrogen. The product ions at m/z 361.1743 and 316.1536 u (experimental values) 
are compatible with the above assumption. From these ions a second fragmentation route, 
which is common to most TPs of IRB, consists of the loss of two atoms of nitrogen from the 
tetraazolic ring to produce the major fragments at 333.1704 and 288.1485 u. The ion at m/z 
195.0912 u is generated from removal of HCN from that at m/z 222.1015 u. The structure 
assigned to IRB-TP4 (Fig. 4B) is also compatible with the ESI(-) MS/MS spectrum of this 
compound (see supplementary information, Fig. S3).  
The ESI(+) MS/MS spectrum of IRB-TP5 (Fig. 5) is very similar to that of IRB-TP3. The most 
significant differences are the fragments at m/z values of 210 and 182 Da in the spectrum of 
IRB-TP5 (Fig. 5) versus those at 194 and 166 obtained for the IRB-TP3 (Fig. 4A). IRB-TP5 is 
proposed to be generated from hydroxylation of IRB-TP3. Probably, hydroxylation takes place 
again in the imine carbon of TP3, evolving into a second amide functionality and a terminal 
carbonyl group to generate IRB-TP5 (Fig. 5). The oxidation of an imine moiety to produce an 
amide has been recently reported during the aqueous photodegradation of the neonicotinoid 
nitenpyram (González-Mariño et al., 2018). This oxidation reaction explains also the formation 
of IRB-TP2, whose identity has been confirmed using an authentic standard. 
 
Losartan 
LOS-TP1 and TP2 are di-halogenated species, Table 3. They are formed through replacement 
of the methanol group, attached to the imidazole cycle of LOS (Table 1), by chlorine (TP1) or 
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bromine (TP2). Likely, the reaction is initiated with an electrophilic attack to carbon number 5 
in this ring, Table 1. Electrophilic halogenation is recognized as one the most common reaction 
of aromatic pollutants with free chlorine (Nika et al., 2017; Negreira et al., 2012). The ESI(-) 
MS/MS spectra (Fig. S4) of both compounds contain an intense cluster of ions (191.0144 and 
234.9635 u for LOS-TP1 and LOS-TP2, respectively) which correspond to the di-halogenated 
imidazole cycle linked to the butyl chain. The analogue fragment in the spectrum of LOS 
appears at m/z 187.0629 u, Fig. S4.  
The MS/MS spectra for LOS-TP3, together with the assigned structure, is shown in Fig. 6. This 
TP is a non-halogenated species, containing two additional atoms of oxygen and losing CClN 
in comparison to LOS, Table 3. Its ESI(+) MS/MS spectrum indicates that the biphenyl group 
attached to the tetraazolic ring has not undergone any modification (product ions at 235.0972 
and 207.0906 u, Fig. 6A). The other intense ion in this spectrum appears at m/z 310.1277 u. 
Formation of LOS-TP3 involves hydroxylation of carbons number 2 and 5 in the imidazole ring 
of LOS (Table 1), followed by further oxidation to the corresponding carbonyl moieties with 
removal of CClN. The ESI(-) MS/MS spectrum (Fig. 6B) is compatible with the structure 
proposed for this compound. Particularly, the ions at 308, 252 and 158 Da (nominal masses) 
contain value information regarding the chains attached to the tertiary atom of nitrogen in the 
molecule of LOS-TP3.  
LOS-TP4 is likely a secondary TP of LOS. It is generated from the loss of the two carbons 
chain bonded to tertiary nitrogen in LOS-TP3. The fragment at m/z 100.0769 u in the ESI(-) 
MS/MS spectrum of the TP (Fig. S5) confirms the existence of a butyl amide group in the 
structure of this species. Finally, LOS-TP5 is a hydroxylated derivative of LOS. The very weak 
signal obtained for this compound prevented obtaining its product ion spectrum; so, the exact 
hydroxylation position could not be investigated. 
3.3. TPs stability and transformation routes 
The time-course of the TPs described in the previous section was followed in samples buffered 
at pH 7, considering reaction times up to 8 h. Fig. 7 shows the profiles obtained for river water 
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aliquots, previously spiked with IRB and LOS, in presence of 2 and 10 mg L-1 of free chlorine, 
respectively. Bromide was not added to the river water aliquots in these experiments. Values 
in the Y axis are normalized responses (ratios between the peak areas of each compound and 
that for the precursor at zero time, multiplied by 100) represented versus reaction time. In the 
particular case of IRB-TP2, the molar yield of its formation has been calculated and plotted 
versus the reaction time. 
As shown in Fig. 7A, the response of IRB-TP2 reached a maximum after 2 h and then, it 
remained practically unchanged. This species is the major TP formed in the reaction of IRB 
with free chlorine. Additional chlorination experiments using water samples spiked with this TP 
demonstrated it negligible degradation after 8 h (less than 5% and 6% in river and ultrapure 
water, respectively) in presence of 10 mg L-1 of chlorine. Responses for IRB-TPs 1 and 3 
remained practically stable after 1 h. Their maximum normalized values represented around 
1% of the IRB response at zero time; thus, they are considered minor TPs. On the other hand, 
the signal of IRB-TP5 increased continuously within the considered reaction time (Fig. 7A), 
which supports the idea of being a secondary TPs or IRB.  
The levels of the halogenated derivatives of LOS (LOS-TPs 1 and 2) reached a maximum after 
4 h, whilst the responses obtained for LOS-TPs 3 and 4 rose steady within the considered 
reaction time (Fig. 7B). The response of the hydroxylated derivative (LOS-TP5) stayed at very 
low levels: around 0.2%. Under experimental conditions considered in Fig. 7 (river water 
containing 0.007 mg L-1 of bromide in presence of 10 mg L-1 of free chlorine), the dichlorinated 
species (LOS-TP1) was the TP formed in a higher extend; however, in bromide richer samples, 
the ratio between the responses for the dichloro (LOS-TP1) and the bromochloro (LOS-TP2) 
derivatives might differ. Such situation is depicted in the supplementary information section 
with the time-course plots of both TPs in river water aliquots spiked with increased 
concentrations of bromide, Fig. S6.  
Taking into account the structures assigned to identified TPs and their time-course during 
chlorination assays, the possible reaction routes of sartans with chlorine are proposed, Fig. 8. 
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IRB-TP2 is the major TP of IRB. It is formed through hydroxylation of the imine double bond, 
with opening of the imidazolone ring. TPs 1, 3 and 4 are generated following competitive 
hydroxylation routes. Structure assigned to IRB-TP1 remains as tentative. IRB-TP5 is a 
secondary TP arising from IRB-TP3. For LOS, electrophilic substitution halogenation appears 
to be the most important of the identified reaction routes. A competitive transformation path 
involves hydroxylation with cleavage of the imidazole ring, followed by further N-dealkylation.  
3.4. Toxicity assessment 
A key issue when oxidative treatments lead to formation of organic derivatives from known 
emerging pollutants is to predict whether the new compounds represent an environmental 
hazard, or not. In this vein, it is convenient to compare the acute and the chronic toxicities of 
the precursor molecules and those corresponding to the identified TPs. In-silico models 
provide preliminary data to answer the above question with a minimum cost. The LC-50 
concentrations for acute and chronic exposure to the investigated compounds, considering 
three different model organisms, are given as supplementary material, Table S2. The ratios 
between their relative LC-50 values (TP/parent drug) are compiled in Table 4. Values below 
the unit correspond to enhanced estimated toxicities, whereas, values above 1 point out to a 
reduced toxicity. The reaction of IRB with free chlorine led to a lower predicted toxicity. 
However, the di-halogenated derivatives of LOS (LOS-TPs 1 and 2), and the secondary 
derivative (LOS-TP4) showed ratios below 1; whereas, that of LOS-TP3 remains around the 
unit. Thus, the interaction of LOS with free chlorine might lead to an enhancement in the toxicity 
of the solution. 
 
4. Conclusions 
The imidazolic-like rings of IRB (imidazolone cycle) and LOS (imidiazole cycle) are responsible 
for their reactivity with free chlorine. On the other hand, the benzoimidazole and the tetraazolic 
biphenyl cycles in the structures of the investigated drugs did not interact with oxidant. Thus, 
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TEL and VAL will remain unchanged during free chlorine treatments employed in the 
production of tap water, whilst IRB and LOS disappear following pseudo-first order kinetics, 
with maximum reaction rates at neutral, or slightly acidic pHs. 
IRB interacts with free chlorine through different hydroxylation and oxidation reactions. The 
most favourable one involves carbon number 2 in the imidazolone cycle, followed by ring 
opening and oxidation of the imine to an amide. LOS mostly undergoes electrophilic 
substitution of methanol by one halogen (chlorine or bromine) in position 5 of the imidazole 
ring. This reaction path competes with cleavage of the same ring, concurrently to double 
hydroxylation and loss of CClN. In-silico predictions point out to a decrease of the toxicity 
during IRB reactions with free chlorine; however, the opposite effect is expected for LOS.  
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Table 1. Chemical structures, CAS number, log D values (pH7) and pKa values of 
sartan compounds considered in the study. 
 
Name Abbreviation CAS number Structure Log D 
(pH 7)a 
pKaa 





































Table 2. Half-lives (t1/2, min, with their errors) measured in water samples buffered at pH 7. 
Initial concentration of free chlorine 2 and 10 mg L-1 for IRB and LOS, respectively. 
Compound Ultrapure water bRiver water  
 Without 
bromide 




a0.100 mg L-1 
bromide 
IRB 21.8 ± 0.8 22.0 ± 0.7 40 ± 2 40 ± 1 
LOS 39.5 ± 0.8 26.0 ± 0.7 39.8 ± 0.8 21 ± 1 
a Added bromide concentration. 






Table 3. Summary of transformation products (TPs) observed during chlorination 













IRB 16.30 C25H28N6O 15 99.52 99.24 428.2333 
IRB-TP1 14.86 C25H28N6O2 15 99.60 80.44 444.2272 
IRB-TP2 16.61 C25H30N6O2 14 98.36 99.33 446.2443 
IRB-TP3 16.17 C25H28N6O2 15 99.45 98.50 444.2272 
IRB-TP4 18.13 C25H28N6O2 15 95.11 83.25 444.2272 
IRB-TP5 15.00 C25H28N6O3 15 83.20 76.38 460.2225 
LOS 16.87 C22H23ClN6O 14 99.59 97.32 422.1622 
LOS-TP1 18.35 C21H20Cl2N6 14 99.04 99.25 426.1123 
LOS-TP2 18.31 C21H20ClBrN6 14 99.67 98.54 470.0621 
LOS-TP3 16.54 C21H23N5O3 13 99.61 99.78 393.1800 
LOS-TP4 15.95 C19H21N5O 12 90.77 97.69 335.1746 
LOS-TP5 15.88 C22H23ClN6O2 14 84.49 97.77 438.1571 






Table 4. Ratios between estimated toxicities (TP/precursor drug) for the TPs of IRB and LOS under acute and chronic exposure. Values 
obtained from the ECOSAR software toxicity predictions. 
 














IRB-TP1 33 44 16 13 23 7 
IRB-TP2 121 180 46 34 72 15 
IRB-TP3 5.9 6.8 4.2 3.5 5.0 2.7 
IRB-TP4 67 94 28 22 43 10 
IRB-TP5 221 367 287 760 6.7 37 
LOS-TP1 0.03 0.12 0.20 0.19 0.11 0.21 
LOS-TP2 0.02 0.09 0.17 0.17 0.09 0.19 
LOS-TP3 1.1 1.3 n.a. 0.95 8 n.a. 
LOS-TP4 0.0005 0.008 0.025 0.275 0.008 n.a. 






Captions to figures. 
Fig. 1. Effect of pH in the half-lives (t1/2 min) of IRB and LOS. Data for ultrapure water 
solutions using 10 mg L-1 of free chlorine, without bromide addition. 
Fig. 2. ESI (+) MS/MS spectra for IRB (A) and IRB-TP1 (B). 
Fig. 3. Proposed structure and ESI (+) (A) and ESI (-) (B) product ion spectra for IRB-TP2. 
Fig. 4. ESI (+) MS/MS spectra of IRB-TP3 (A) and IRB-TP4 (B). 
Fig. 5. Structure and ESI (+) MS/MS spectra of IRB-TP5. 
Fig. 6. Chemical structure and ESI (+) (A) and ESI (-) (B) product ion scan spectra for LOS-
TP3. 
Fig. 7. Time-course of TPs identified in the chlorination experiments using river water 
aliquots. A, data for IRB in presence of 2 mg L-1 of chlorine. B, data for LOS using 10 mg L-1 
of chlorine.  
Fig. 8. Proposed reaction pathways for IRB (A) and LOS (B) in chlorinated water samples. 
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+ Product Ion (rt: 16.568-16.737 min, 5 scans) (447.25049[z=1] -> 20 eV
Counts vs. Mass-to-Charge (m/ z)




















































+ESI Product Ion (rt: 16.109-16.278 min, 5 scans) Frag=160.0V CID@10.0 (445.2353[z=1] -> **)
Counts vs. Mass-to-Charge (m/z)































+ESI Product Ion (rt: 18.122-18.251 min, 7 scans) Frag=170.0V CID@20.0 (445.2353[z=1] 






























































































+ESI Product Ion (rt: 15.024-15.151 min, 4 scans) CID@10.0 (461.2290[z=1] -> **)
Counts v s. M ass-to-Charge (m/z)
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Table S1. Half-life (t1/2, min) values, determination coefficients (R2) for natural logarithmic 
plots of normalized responses (peak area divided by the peak area of the parent drug at 
zero time) versus reaction time, and second-order reaction rate constants (k, M-1, min-1) 
for IRB and LOS in ultrapure water solutions containing 10 mg L-1 (1.41 x 10-4 M) of free 
chlorine. 
 







35 ± 1 
14 ± 1 
6.2 ± 0.2 
21.9 ± 0.5 






149 ± 5 
345 ± 32 
836 ± 24 
236 ± 5 







9.4 ± 0.1 
18.3 ± 0.6 
39.5 ± 0.8 
281 ± 7 






549 ± 8 
282 ± 9 
131 ± 3 
18.4  ±  0.5 






Table S2. Ecotoxicological estimated data for acute and chronic exposure to IRB, LOS and their TPs. Predicted values obtained using the 
ECOSAR software. Chemical families employed in the QSAR predictions were amides (IRB and its TPs) and diazoles (LOS and its TPs). 
 
 Acute toxicity (mg L-1) Chronic toxicity (mg L-1) 
Compound 
Fish 




EC50 (96 h) 
Fish  Daphnid Algae  
IRB 0.32 0.19  0.13 0.02 0.1 0.35 
IRB TP1 10.64 8.44 2.11 0.25 2.3 2.45 
IRB TP2 38.77 34.18 5.97 0.67 7.19 5.08 
IRB TP3 1.89 1.29 0.54 0.07 0.50 0.96 
IRB TP4 21.37 17.87 3.7 0.43 4.25 3.64 
IRB TP5 70.59 69.72 37.36 15.19 0.67 12.88 
LOS 0.23 1.69 0.24 0.04 0.03 0.14 
LOS TP1 0.0068 0.196 0.047 0.0077 0.0034 0.03 
LOS TP2 0.0043 0.154 0.04 0.0066 0.0027 0.027 
LOS TP3 0.263 2.22 n.a. 0.038 0.241 n.a. 
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Fig. S5. Time-course of the dichloro (LOS-TP1) and the bromochloro (LOS-TP2) TPs of LOS 
in river water as function of the added bromide concentration. Data obtained at pH 7, using 10 
mg L-1 as the initial concentration of free chlorine. The unspiked water matrix contained 0.007 
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